Showing results (21-30 of 411) with videos related to
Sort By:
Pageof 42
Cancer Treatment Reviews|April 25, 2014
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastasesStefan Zimmermann, Rafal Dziadziuszko, Solange PetersJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2023
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?Dipesh Uprety, Jordi Remon, Solange PetersCell|January 28, 2021
Strength in numbers: predicting response to checkpoint inhibitors from large clinical datasetsAlbrecht Stenzinger, Daniel Kazdal, Solange PetersTranslational Lung Cancer Research|May 17, 2023
Adjuvant therapies in stages I-III epidermal growth factor receptor-mutated lung cancer: current and future perspectivesMark G Kris, Tetsuya Mitsudomi, Solange PetersCancer Discovery|April 3, 2021
Treatment Decisions for Patients with Cancer during the COVID-19 PandemicChris Labaki, Solange Peters, Toni K ChoueiriCancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David BarbieExpert Review of Anticancer Therapy|October 18, 2011
Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?Antonio Passaro, Enrico Cortesi, Filippo de MarinisJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2022
Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage Resectable Non-Small-Cell Lung CancerAntonio Passaro, Ilaria Attili, Filippo de MarinisCancer Treatment Reviews|July 17, 2014
Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactionsSolange Peters, Stefan Zimmermann, Alex A AdjeiRevue Medicale Suisse|December 18, 2015
[Is prescription of a therapy costing 150,000 CHF reasonable?]Solange Peters, Roger von Moos, Beat ThurlimannPageof 42